A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in ...

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment ...

The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) with or without ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), including in people without a diagnosis of lupus nephritis (LN, lupus-related ...

Find out more about lupus: the symptoms, types, causes, and who is at risk for developing this chronic autoimmune disease.

Watch the episode of the The Expert Series: Lupus and Men. Learn more about the prevalence of lupus in men, support groups for men, and more.

The Lupus Foundation of America provides education and support services to people affected by lupus. We collaborate with experts to provide clear, easy-to-use information, programs and resources to ...

Here is a quick reference checklist of lupus travel essentials to use when packing for a trip. Don’t forget to talk with your doctor as you plan your trip to get any pretravel medical advice you might ...

I know my story isn’t over yet — I take it one day at a time and keep fighting. Lupus may be part of my life, but it does not define all of who I am.

The U.S. Food and Drug Administration has approved Saphnelo™ (anifrolumab-fnia) for use as a treatment for adults with systemic lupus erythematosus (SLE).